Microbial Identification Market Size, Share & Trends Report

Microbial Identification Market Size, Share & Trends Analysis Report By Product & Services, By Technology (Mass Spectrometry, PCR), By Method, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-4-68040-192-4
Number of Pages: 130
Format: Electronic (PDF)

Historical Range: 2018 - 2023
Industry: Healthcare

Market Segmentation

Microbial Identification Market Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
- Instruments
- Consumables
- Software & Services
Microbial Identification Market Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Mass Spectrometry
- PCR
- Microarrays
- Next Generation Sequencing
- Others
Microbial Identification Market Method Outlook (Revenue, USD Million, 2018 - 2030)
- Phenotypic Methods
- Genotypic Methods
- Proteotypic Methods
Microbial Identification Market Application Outlook (Revenue, USD Million, 2018 - 2030)
- Clinical Diagnostics
- Pharmaceuticals
- Food & Beverage Testing
- Environmental Application
- Others
Microbial Identification Market End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Laboratories
- Food Testing Laboratories
- Others
Microbial Identification Market Regional Outlook (Revenue, USD Million; 2018 - 2030)
- North America
  - North America Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
    - Instruments
    - Consumables
    - Software & Services
  - North America Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Mass Spectrometry
    - PCR
    - Microarrays
    - Next Generation Sequencing
    - Others
  - North America Method Outlook (Revenue, USD Million, 2018 - 2030)
    - Phenotypic Methods
    - Genotypic Methods
    - Proteotypic Methods
  - North America Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Clinical Diagnostics
    - Pharmaceuticals
    - Food & Beverage Testing
    - Environmental Application
    - Others
  - North America End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical and Biotechnology Companies
    - Hospitals and Diagnostic Laboratories
    - Food Testing Laboratories
    - Others
  - U.S.
    - U.S. Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - U.S. Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - U.S. Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - U.S. Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - U.S. End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - Canada
    - Canada Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - Canada Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - Canada Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - Canada Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - Canada End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
- Europe
  - Europe Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
    - Instruments
    - Consumables
    - Software & Services
  - Europe Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Mass Spectrometry
    - PCR
    - Microarrays
    - Next Generation Sequencing
    - Others
  - Europe Method Outlook (Revenue, USD Million, 2018 - 2030)
    - Phenotypic Methods
    - Genotypic Methods
    - Proteotypic Methods
  - Europe Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Clinical Diagnostics
    - Pharmaceuticals
    - Food & Beverage Testing
    - Environmental Application
    - Others
  - Europe End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical and Biotechnology Companies
    - Hospitals and Diagnostic Laboratories
    - Food Testing Laboratories
    - Others
  - UK
    - UK Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - UK Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - UK Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - UK Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - UK End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - Germany
    - Germany Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - Germany Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - Germany Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - Germany Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - Germany End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - France
    - France Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - France Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - France Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - France Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - France End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - Italy
    - Italy Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - Italy Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - Italy Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - Italy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - Italy End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - Spain
    - Spain Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - Spain Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - Spain Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - Spain Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - Spain End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - Denmark
    - Denmark Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - Denmark Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - Denmark Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - Denmark Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - Denmark End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - Sweden
    - Sweden Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - Sweden Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - Sweden Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - Sweden Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - Sweden End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - Norway
    - Norway Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - Norway Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - Norway Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - Norway Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - Norway End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
- Asia-Pacific
  - Asia Pacific Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
    - Instruments
    - Consumables
    - Software & Services
  - Asia-Pacific Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Mass Spectrometry
    - PCR
    - Microarrays
    - Next Generation Sequencing
    - Others
  - Asia-Pacific Method Outlook (Revenue, USD Million, 2018 - 2030)
    - Phenotypic Methods
    - Genotypic Methods
    - Proteotypic Methods
  - Asia-Pacific Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Clinical Diagnostics
    - Pharmaceuticals
    - Food & Beverage Testing
    - Environmental Application
    - Others
  - Asia-Pacific End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical and Biotechnology Companies
    - Hospitals and Diagnostic Laboratories
    - Food Testing Laboratories
    - Others
  - Japan
    - Japan Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - Japan Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - Japan Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - Japan Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - Japan End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - China
    - China Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - China Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - China Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - China Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - China End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - India
    - India Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - India Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - India Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - India Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - India End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - Australia
    - Australia Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - Australia Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - Australia Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - Australia Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - Australia End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - Thailand
    - Thailand Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - Thailand Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - Thailand Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - Thailand Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - Thailand End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - South Korea
    - South Korea Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - South Korea Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - South Korea Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - South Korea Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - South Korea End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
- Latin America
  - Latin America Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
    - Instruments
    - Consumables
    - Software & Services
  - Latin America Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Mass Spectrometry
    - PCR
    - Microarrays
    - Next Generation Sequencing
    - Others
  - Latin America Method Outlook (Revenue, USD Million, 2018 - 2030)
    - Phenotypic Methods
    - Genotypic Methods
    - Proteotypic Methods
  - Latin America Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Clinical Diagnostics
    - Pharmaceuticals
    - Food & Beverage Testing
    - Environmental Application
    - Others
  - Latin America End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical and Biotechnology Companies
    - Hospitals and Diagnostic Laboratories
    - Food Testing Laboratories
    - Others
  - Brazil
    - Brazil Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - Brazil Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - Brazil Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - Brazil Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - Brazil End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - Mexico
    - Mexico Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - Mexico Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - Mexico Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - Mexico Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - Mexico End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - Argentina
    - Argentina Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - Argentina Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - Argentina Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - Argentina Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - Argentina End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
- Middle East & Africa
  - Middle East & Africa Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
    - Instruments
    - Consumables
    - Software & Services
  - Middle East & Africa Technology Outlook (Revenue, USD Million, 2018 - 2030)
    - Mass Spectrometry
    - PCR
    - Microarrays
    - Next Generation Sequencing
    - Others
  - Middle East & Africa Method Outlook (Revenue, USD Million, 2018 - 2030)
    - Phenotypic Methods
    - Genotypic Methods
    - Proteotypic Methods
  - Middle East & Africa Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Clinical Diagnostics
    - Pharmaceuticals
    - Food & Beverage Testing
    - Environmental Application
    - Others
  - Middle East & Africa End-use Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical and Biotechnology Companies
    - Hospitals and Diagnostic Laboratories
    - Food Testing Laboratories
    - Others
  - South Africa
    - South Africa Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - South Africa Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - South Africa Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - South Africa Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - South Africa End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - Saudi Arabia
    - Saudi Arabia Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - Saudi Arabia Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - Saudi Arabia Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - Saudi Arabia Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - Saudi Arabia End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - UAE
    - UAE Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - UAE Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - UAE Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - UAE Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - UAE End-use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others
  - Kuwait
    - Kuwait Product & Services Outlook (Revenue, USD Million, 2018 - 2030)
      - Instruments
      - Consumables
      - Software & Services
    - Kuwait Technology Outlook (Revenue, USD Million, 2018 - 2030)
      - Mass Spectrometry
      - PCR
      - Microarrays
      - Next Generation Sequencing
      - Others
    - Kuwait Method Outlook (Revenue, USD Million, 2018 - 2030)
      - Phenotypic Methods
      - Genotypic Methods
      - Proteotypic Methods
    - Kuwait Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Clinical Diagnostics
      - Pharmaceuticals
      - Food & Beverage Testing
      - Environmental Application
      - Others
    - Kuwait End-useOutlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals and Diagnostic Laboratories
      - Food Testing Laboratories
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.